3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
115
Myelodysplastic Syndromes
109
Precursor Cell Lymphoblastic Leukemia-Lymphoma
95
Leukemia
74
Hodgkin Disease
73
Leukemia, Lymphocytic, Chronic, B-Cell
72
Multiple Myeloma
71
Lymphoma, Non-Hodgkin
71
Lymphoma
66
Myeloproliferative Disorders
54
Graft vs Host Disease
50
Lymphoma, Follicular
49
Lymphoma, Mantle-Cell
47
Leukemia, Myeloid, Accelerated Phase
47
Lymphoma, Large B-Cell, Diffuse
46
Congenital Abnormalities
46
Leukemia, Myelomonocytic, Chronic
44
Lymphoma, B-Cell, Marginal Zone
43
Hematologic Neoplasms
43
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
42
Leukemia, Myeloid, Chronic-Phase
41
Burkitt Lymphoma
40
Primary Myelofibrosis
39
Blast Crisis
38
Neoplasms, Plasma Cell
37
Lymphoma, Large-Cell, Immunoblastic
32
Waldenstrom Macroglobulinemia
25
Myelodysplastic-Myeloproliferative Diseases
24
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
24
Lymphoma, T-Cell, Cutaneous
23
Interventions
Mitomycin
3
Hyperthermic Intraperitoneal Chemotherapy
3
Surveys and Questionnaires
2
Fluorouracil
2
Capecitabine
2
tislelizumab
1
molgramostim
1
irinotecan sucrosofate
1
Tacrolimus
1
Standard of Care
1
Sirolimus
1
Referral and Consultation
1
Radiosurgery
1
Psychiatric Rehabilitation
1
Pharmacogenomic Testing
1
Oxaliplatin
1
Observation
1
Methods
1
Leucovorin
1
Lansoprazole
1
Ifosfamide
1
Gemcitabine
1
Early Intervention, Educational
1
Doxorubicin
1
Cytoreduction Surgical Procedures
1
Clarithromycin
1
Cisplatin
1
Carboplatin
1
Bromelains
1
Behavior Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pseudomyxoma Peritonei
×
Tacrolimus
×
Clear all
NCT06084780
2026-06-05
TRANSCAPE
Case Comprehensive Cancer Center
Phase 2
Not yet recruiting
20 enrolled